A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...
A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to ...
The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently ...
New machine learning techniques plumb vast "data lakes" to help researchers design faster, cheaper, more effective clinical ...
Regulators in the U.S. and Europe recently determined that a popular group of drugs for weight loss and diabetes don't heighten the risk of suicide. New data published in the Journal of the American ...
The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...
Channel 13's Abel Garcia met with a local and a doctor to get your questions and concerns answered over new weight loss drugs LAS VEGAS (KTNV) — Chances are you or someone you know is taking one ...
But a new report from the Centers for Disease Control and Prevention’s National Center for Health Statistics highlights that accessing these necessary drugs isn’t always simple — about 1 in 5 older ...
Shilpa Medicare (SML) climbed 6.12% to Rs 811.25 after the company announced that it has submitted new drug application (NDA) to U.S. Food and Drug Administration (USFDA) for Oxylanthanum Carbonate.
today announced an update for its New Drug Application for Ketamine from the U.S. Food and Drug Administration (the “FDA”) with an assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA ...